Speciality Areas
Foot and Ankle Sports Surgery
Dr Sidhu offers non-surgical and surgical treatment for a variety of Foot and Ankle Sports conditions, including Achilles tendon ruptures (for which he uses the mid-substance SpeedBridge repair), syndesmosis injuries (high ankle sprains), fractures (ankle fractures, navicular stress fractures and Jones fractures), Lisfranc/midfoot injuries and recurrent ankle instability.
During his fellowship in Philadelphia, he spent time treating professional athletes from the Philadelphia Eagles (NFL) and Philadelphia Phillies (Major League Baseball) as well as athletes from the surrounding Division 1 NCAA Colleges (Villanova, Rutgers and St Joseph’s) and Princeton University.
Dr Sidhu also trained at foot and ankle surgical facilities in Florida (Arthrex), Colorado (Paragon 28) and Tennessee (Smith and Nephew) learning how to perform the most up to date procedures in the treatment for the above conditions.
Ankle Replacement Surgery
Ankle Replacement Surgery is a pain-relieving procedure for patients with end stage ankle arthritis, who have failed non-surgical treatment. It allows preservation of ankle joint movement and can prevent arthritis of the surrounding foot and ankle joints, that can occur after Ankle Fusion Surgery.
Dr Sidhu offers Ankle Replacement Surgery and Talus Replacement Surgery for eligible patients. During his fellowship in Philadelphia, Dr Sidhu performed over 80 ankle replacement surgery procedures, including primary and revision ankle replacement surgery.
Bunion Surgery and Minimally Invasive Foot and Ankle Surgery
The majority of patients with bunion deformities do not require surgery. Surgery is reserved for patients with daily pain over the bunion and limitation of day to day activities due to pain.
Dr Sidhu has trained in minimally invasive (key-hole) foot and ankle surgery and offers minimally invasive Bunion Correction Surgery. This involves using a 5 small incisions on the inside of the foot in order to correct the bunion deformity. After this procedure, patients can weight bear through their heel for 2 weeks and then fully weight bear from 2 weeks onwards.
For further information regarding this procedure, please contact our office.
Orthopaedic Trauma
Dr Sidhu is a member of the Orthopaedic Trauma on-call Roster at Royal Prince Alfred Hospital (a Level 1 Trauma Centre). Dr Sidhu completed terms at St George, Liverpool and The Canberra Hospitals (all Level 1 Adult Trauma Centres) and Westmead Children’s Hospital (paediatric Level 1 trauma centre) during his registrar training and then undertook two additional years of training as the Orthopaedic Trauma Fellow at Royal Prince Alfred Hospital between 2020 and 2022.
He is experienced in the treatment of upper and lower limb injuries in both adult and paediatric patients.
Clinical Research
Dr Sidhu holds a keen interest in orthopaedic research. He is one of the research leads for the Department of Orthopaedic Surgery at Royal Prince Alfred Hospital in Sydney.
He is currently undertaking a PhD through UNSW Sydney. The focus of his research is investigating medications which can reduce the risk of venous thromboembolism (deep venous thrombosis and pulmonary embolus) after hip and knee replacement surgery.
Publications
- Sidhu VS, et al. Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study. BMC Musculoskeletal Disorders. August, 2023.
- Sidhu VS, et al. Effect of Aspirin Vs Enoxaparin on 90-day Mortality in Patients Undergoing Hip or Knee Arthroplasty: A Secondary Analysis of the CRISTAL Cluster Randomized Trial. JAMA Network Open. June 2023.
- Sidhu VS, et al. Post-discharge patient-reported non-adherence to aspirin compared to enoxaparin for venous thromboembolism prophylaxis after hip or knee arthroplasty. ANZJS. January 2023.
- Sidhu VS, et al. Is Enoxaparin associated with a Higher Risk of Persistent Wound Drainage Than Aspirin? A Secondary Analysis of Data From the CRISTAL Randomized Trial. CORR. January 2023.
- Sidhu VS, Harris IA. Aspirin Vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty – Reply. JAMA. January 2023
- Sidhu VS, et al. Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial. JAMA. 2022; 328(8): 719-727.
- Sidhu VS, Kelly T L, Pratt N, Graves SE, Buchbinder R, Naylor JM et al. CRISTAL: statistical analysis plan. Trials. 2021. Published online 24 August 2021
- Sidhu VS, Cheng TL, Lillia J, Bridge C, Little DG, Gray RJ. 3D Printed Models can Guide Safe Halo Pin Placement in Patients with Diastrophic Dysplasia. Spine Deformity Journal. Article in Press.
- Harris IA, Sidhu VS, Mittal R, Adie S. Surgery for chronic musculoskeletal pain: the question of evidence. PAIN. 161 S95 – S103
- Farey JE, An VVG, Sidhu VS, Karunaratne S, Harris IA. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis. Orthopaedics & Traumatology: Surgery & Research. July, 2020.
- Sidhu VS, Graves SE, Buchbinder R, Naylor JM et al. CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study. BMJ Open. 2019;9(11):
- Harris IA & Sidhu VS. Aspirin as venous thromboembolic event prophylaxis post total hip and knee arthroplasty (Editorial). ANZ Journal of Surgery. 2019;89(10):1184-5.
- Sidhu VS, Hermans D & Duckworth DG. The operative outcomes of displaced medial-end clavicle fractures. Journal of Shoulder and Elbow Surgery. 2015;24(11):1728-34.
Presentations
- Sidhu VS et al. Is Enoxaparin Associated with a higher risk of persistent wound drainage than aspirin? A Secondary Analysis of the CRISTAL Randomised Trial. Presented at the 2023 Australian Orthopaedic Association Annual Scientific Meeting, on the 15th of November, 2023.
- Sidhu VS and CRISTAL Study Group. CRISTAL – Aspirin or Enoxaparin for VTE Prophylaxis After THA/TKA. Presented at the 2023 ACTA Registry ASM in Melbourne, Australia on the 20th of October, 2023.
- Sidhu VS, Adams A, Kachooei AR, Paladino J, Whiting C, Denbleyker M, Corr D, Raikin SM, Pedowitz DI. Routine Postoperative Aspirin for VTE Chemoprophylaxis in Primary Total Ankle Arthroplasty. Presented at the 2022 AOFAS (American Orthopaedic Foot and Ankle Society) Annual Meeting in Quebec City on the 17th September, 2023.
- Sidhu VS, Lilia J, Cheng TL, Keane C, Little DG, Gray RJ. 3D Models Can Guide Safe Halo Pin Placement in Patients with Diastrophic Dysplasia. Presented at the 2020 Spine Society Australia (SSA) Conference on the 13th November, 2020.
- Sidhu VS. My PhD path – How I Started? Presented at the 2019 Australian Orthopaedic Association Annual Scientific Meeting Research Symposium on the 8th October, 2019
- Sidhu VS, Hawke H, Naylor J, Churches T, Gosbell I, Lin C, Xuan W, Fletcher J, Harris IA. VTE Rates in Patients Undergoing Total Joint Arthroplasty in Australia: A Comparison of Aspirin and Low Molecular Weight Heparin. Presented at the 2017 ACT AOA ASM in Canberra, on the 1st December, 2017
- Sidhu VS, Hermans D, Duckworth DG. The Operative Outcomes of Displaced Medial-End Clavicle Fractures. Presented at the 2014 Australian Orthopaedic Association ASM, in Melbourne on the 16th October, 2014
